Pacific Edge Ltd (PEB) - Product Pipeline Analysis, 2018 Update

  • ID: 4435449
  • Company Profile
  • 39 pages
  • GlobalData
1 of 5
Summary

Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. PEB offers services such as molecular oncology, bioinformatics, cancer genetics, clinical research, technology commercialisation, marketing and sales, among others. The company offers diagnostic services through its facilities located in Australia, New Zealand, and the US. PEB is headquartered in Dunedin, New Zealand.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Pacific Edge Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Pacific Edge Ltd Company Overview
Pacific Edge Ltd Company Snapshot
Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview
Pacific Edge Ltd – Pipeline Analysis Overview
Pacific Edge Ltd - Key Facts
Pacific Edge Ltd - Major Products and Services
Pacific Edge Ltd Pipeline Products by Development Stage
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status
Pacific Edge Ltd Pipeline Products Overview
Cxbladder
Cxbladder Product Overview
Cxbladder Clinical Trial
Cxbladder - Health
Cxbladder - Health Product Overview
Cxbladder - Prognosis Assay
Cxbladder - Prognosis Assay Product Overview
Cxcolorectal - Prognosis Gen I
Cxcolorectal - Prognosis Gen I Product Overview
Cxcolorectal - Prognosis Gen II
Cxcolorectal - Prognosis Gen II Product Overview
Diagnostic Assay - Gastric Cancer
Diagnostic Assay - Gastric Cancer Product Overview
Endometrial Cancer Detection Assay
Endometrial Cancer Detection Assay Product Overview
Gastric Cancer Triage Immunoassay
Gastric Cancer Triage Immunoassay Product Overview
Prognostic Assay - Melanoma
Prognostic Assay - Melanoma Product Overview
Pacific Edge Ltd - Key Competitors
Pacific Edge Ltd - Key Employees
Pacific Edge Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Pacific Edge Ltd, Recent Developments
May 29, 2018: Pacific Edge Announces Preliminary Results for Year Ended 31 March 2018
May 24, 2018: Cxbladder Monitor Demonstrates Clinical Utility In Patients Being Monitored For Recurrent Bladder Cancer (UC)
Nov 29, 2017: Pacific Edge: FY18 Interim Results
Aug 03, 2017: Cxbladder Test Suite Adopted by MidCentral DHB
May 24, 2017: Pacific Edge: Full Year Results to 31 March 2017
Apr 12, 2017: Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients
Mar 21, 2017: Callaghan Innovation Growth Grant for Pacific Edge
Mar 06, 2017: Cxbladder Monitor Significantly Outperforms FDA Approved Urine Tests for Bladder Cancer
Dec 15, 2016: Pacific Edge Launches Cxbladder Resolve - The Fourth Product in Suite of Cxbladder Tests
Dec 13, 2016: Pacific Edge Commences Official Launch Of Cxbladder Monitor In The USA
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview
Pacific Edge Ltd Pipeline Products by Equipment Type
Pacific Edge Ltd Pipeline Products by Indication
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status
Pacific Edge Ltd, Key Facts
Pacific Edge Ltd, Major Products and Services
Pacific Edge Ltd Number of Pipeline Products by Development Stage
Pacific Edge Ltd Pipeline Products Summary by Development Stage
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status
Pacific Edge Ltd Ongoing Clinical Trials Summary
Cxbladder - Product Status
Cxbladder - Product Description
Cxbladder - A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC)
Cxbladder - Health - Product Status
Cxbladder - Health - Product Description
Cxbladder - Prognosis Assay - Product Status
Cxbladder - Prognosis Assay - Product Description
Cxcolorectal - Prognosis Gen I - Product Status
Cxcolorectal - Prognosis Gen I - Product Description
Cxcolorectal - Prognosis Gen II - Product Status
Cxcolorectal - Prognosis Gen II - Product Description
Diagnostic Assay - Gastric Cancer - Product Status
Diagnostic Assay - Gastric Cancer - Product Description
Endometrial Cancer Detection Assay - Product Status
Endometrial Cancer Detection Assay - Product Description
Gastric Cancer Triage Immunoassay - Product Status
Gastric Cancer Triage Immunoassay - Product Description
Prognostic Assay - Melanoma - Product Status
Prognostic Assay - Melanoma - Product Description
Pacific Edge Ltd, Key Employees
Pacific Edge Ltd, Subsidiaries
Glossary

List of Figures
Pacific Edge Ltd Pipeline Products by Equipment Type
Pacific Edge Ltd Pipeline Products by Development Stage
Pacific Edge Ltd Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Metlifecare Ltd
  • Fisher & Paykel Healthcare Corporation Ltd
  • Rubicon Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll